This page includes the latest FDA filings for Nabriva Therapeutics Us Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Nabriva Therapeutics US, Inc., Merck Sharp & Dohme Corp. | Prescription Medication | 2024-11-22 |
| Nabriva Therapeutics US, Inc., Nabriva Therapeutics Ireland DAC, SEL Biochem Xinjiang Co., Ltd, Hovione Limited, Charles River Laboratories, Hovione FarmaCiencia SA Central Stability Laboratory, Patheon Italia S.p.A, Fresenius Kabi Norge AS, Almac Pharma Services | Prescription Medication | 2024-10-13 |
| Nabriva Therapeutics US, Inc., Nabriva Therapeutics Ireland DAC, SEL Biochem Xinjiang Co., Ltd, Hovione Limited, Charles River Laboratories, Hovione FarmaCiencia SA Central Stability Laboratory, Patheon Italia S.p.A, Fresenius Kabi Norge AS, Almac Pharma Services | Prescription Medication | 2022-12-28 |
| Nabriva Therapeutics US, Inc., Merck Sharp & Dohme Corp. | Prescription Medication | 2022-10-19 |
| Nabriva Therapeutics US, Inc., Merck Sharp & Dohme Corp. | Prescription Medication | 2022-08-05 |
| Nabriva Therapeutics US, Inc., Merck Sharp & Dohme Corp. | Prescription Medication | 2022-06-24 |
| Nabriva Therapeutics US, Inc., Merck Sharp & Dohme Corp. | Prescription Medication | 2021-12-04 |
| Nabriva Therapeutics US, Inc., Nabriva Therapeutics Ireland DAC, SEL Biochem Xinjiang Co., Ltd, Hovione Limited, Charles River Laboratories, Hovione FarmaCiencia SA Central Stability Laboratory, Patheon Italia S.p.A, Fresenius Kabi Norge AS, Almac Pharma Services | Prescription Medication | 2021-10-15 |
| Nabriva Therapeutics US, Inc., Nabriva Therapeutics Ireland DAC, SEL Biochem Xinjiang Co., Ltd, Hovione Limited, Charles River Laboratories, Hovione FarmaCiencia SA Central Stability Laboratory, Patheon Italia S.p.A, Fresenius Kabi Norge AS, Almac Pharma Services | Prescription Medication | 2021-10-09 |
| Nabriva Therapeutics US, Inc., Merck Sharp & Dohme Corp. | Prescription Medication | 2021-07-16 |
| Nabriva Therapeutics US, Inc., Merck Sharp & Dohme Corp. | Prescription Medication | 2021-04-03 |
| Nabriva Therapeutics US, Inc., Nabriva Therapeutics Ireland DAC, SEL Biochem Xinjiang Co., Ltd, Hovione Limited, Charles River Laboratories, Hovione FarmaCiencia SA Central Stability Laboratory, Patheon Italia S.p.A, Fresenius Kabi Norge AS, Almac Pharma Services | Prescription Medication | 2021-03-17 |
| Nabriva Therapeutics US, Inc., Nabriva Therapeutics Ireland DAC, SEL Biochem Xinjiang Co., Ltd, Hovione Limited, Charles River Laboratories, Hovione FarmaCiencia SA Central Stability Laboratory, Patheon Italia S.p.A, Fresenius Kabi Norge AS, Almac Pharma Services | Prescription Medication | 2020-04-16 |
| Nabriva Therapeutics US, Inc. | Xenleta | 2019-09-09 |
| Nabriva Therapeutics US, Inc. | Xenleta | 2019-09-09 |
| Nabriva Therapeutics US, Inc. | Citric Buffered Normal Saline | 2019-09-09 |
| Nabriva Therapeutics US, Inc., Nabriva Therapeutics Ireland DAC, SEL Biochem Xinjiang Co., Ltd, Hovione Limited, Charles River Laboratories, Hovione FarmaCiencia SA Central Stability Laboratory, Patheon Italia S.p.A, Fresenius Kabi Norge AS, Almac Pharma Services | Prescription Medication | 2019-09-09 |
| Nabriva Therapeutics US, Inc. | SIVEXTRO | 2014-06-20 |
| Nabriva Therapeutics US, Inc. | SIVEXTRO | 2014-06-20 |
| NCAGE Code | 7F8P1 | NABRIVA THERAPEUTICS US, INC. |
| CAGE Code | 7F8P1 | NABRIVA THERAPEUTICS US, INC. |
| S.A.M. Registration | 7F8P1 [72863844] | NABRIVA THERAPEUTICS US, INC. |
| Import ID | Shipment | Cargo Description | Quantity |
|---|---|---|---|
| 20200711586 | Napoli,Italy -> New York/Newark Area, Newark, New Jersey | MEDICINAL SPECIALITIES | 277 CTN |
| 202005214654 | Napoli,Italy -> New York/Newark Area, Newark, New Jersey | MEDICINAL SPECIALITIES | 277 CTN |
| 2020051123690 | Napoli,Italy -> New York/Newark Area, Newark, New Jersey | MEDICINAL SPECIALITIES | 277 CTN |